These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25348698)

  • 1. Is implementation of the 2013 Australian treatment guidelines for posttraumatic stress disorder cost-effective compared to current practice? A cost-utility analysis using QALYs and DALYs.
    Mihalopoulos C; Magnus A; Lal A; Dell L; Forbes D; Phelps A
    Aust N Z J Psychiatry; 2015 Apr; 49(4):360-76. PubMed ID: 25348698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of cognitive behavioural therapy and selective serotonin reuptake inhibitors for major depression in children and adolescents.
    Haby MM; Tonge B; Littlefield L; Carter R; Vos T
    Aust N Z J Psychiatry; 2004 Aug; 38(8):579-91. PubMed ID: 15298580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of psychological treatments for post-traumatic stress disorder in adults.
    Mavranezouli I; Megnin-Viggars O; Grey N; Bhutani G; Leach J; Daly C; Dias S; Welton NJ; Katona C; El-Leithy S; Greenberg N; Stockton S; Pilling S
    PLoS One; 2020; 15(4):e0232245. PubMed ID: 32353011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of cognitive therapy as an early intervention for post-traumatic stress disorder in children and adolescents: a trial based evaluation and model.
    Shearer J; Papanikolaou N; Meiser-Stedman R; McKinnon A; Dalgleish T; Smith P; Dixon C; Byford S
    J Child Psychol Psychiatry; 2018 Jul; 59(7):773-780. PubMed ID: 29197091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.
    Heuzenroeder L; Donnelly M; Haby MM; Mihalopoulos C; Rossell R; Carter R; Andrews G; Vos T
    Aust N Z J Psychiatry; 2004 Aug; 38(8):602-12. PubMed ID: 15298582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of psychological interventions for children and young people with post-traumatic stress disorder.
    Mavranezouli I; Megnin-Viggars O; Trickey D; Meiser-Stedman R; Daly C; Dias S; Stockton S; Pilling S
    J Child Psychol Psychiatry; 2020 Jun; 61(6):699-710. PubMed ID: 31654414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-utility analysis of different treatments for post-traumatic stress disorder in sexually abused children.
    Gospodarevskaya E; Segal L
    Child Adolesc Psychiatry Ment Health; 2012 Apr; 6():15. PubMed ID: 22490433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and Treatment of Posttraumatic Stress Disorder in Wildfire Evacuees: A Cost-Utility Analysis.
    Lebenbaum M; Hassan SA
    MDM Policy Pract; 2024; 9(1):23814683241260423. PubMed ID: 38904072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of stepped care for the treatment of anxiety disorders in adults: A model-based economic analysis for the Australian setting.
    Stiles JA; Chatterton ML; Le LK; Lee YY; Whiteford H; Mihalopoulos C
    J Psychosom Res; 2019 Oct; 125():109812. PubMed ID: 31442844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of prolonged exposure therapy versus pharmacotherapy and treatment choice in posttraumatic stress disorder (the Optimizing PTSD Treatment Trial): a doubly randomized preference trial.
    Le QA; Doctor JN; Zoellner LA; Feeny NC
    J Clin Psychiatry; 2014 Mar; 75(3):222-30. PubMed ID: 24717377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic Evaluation of Concise Cognitive Behavioural Therapy and/or Pharmacotherapy for Depressive and Anxiety Disorders.
    Meuldijk D; Carlier IV; van Vliet IM; van Hemert AM; Zitman FG; van den Akker-van Marle ME
    J Ment Health Policy Econ; 2015 Dec; 18(4):175-83. PubMed ID: 26729009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internet-Delivered Cognitive Behavioural Therapy for Post-traumatic Stress Disorder or Acute Stress Disorder: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(9):1-120. PubMed ID: 34527087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial.
    Marseille E; Mitchell JM; Kahn JG
    PLoS One; 2022; 17(2):e0263252. PubMed ID: 35213554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of a PTSD Intervention Tailored for Individuals With Severe Mental Illness.
    Slade EP; Gottlieb JD; Lu W; Yanos PT; Rosenberg S; Silverstein SM; Minsky SK; Mueser KT
    Psychiatr Serv; 2017 Dec; 68(12):1225-1231. PubMed ID: 28712353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD.
    Marseille E; Kahn JG; Yazar-Klosinski B; Doblin R
    PLoS One; 2020; 15(10):e0239997. PubMed ID: 33052965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of zuranolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United States.
    O'Callaghan L; Chertavian E; Johnson SJ; Ferries E; Deligiannidis KM
    J Med Econ; 2024; 27(1):492-505. PubMed ID: 38465615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cost-Effectiveness of Cognitive Behavioral Therapy Versus Second-Generation Antidepressants for Initial Treatment of Major Depressive Disorder in the United States: A Decision Analytic Model.
    Ross EL; Vijan S; Miller EM; Valenstein M; Zivin K
    Ann Intern Med; 2019 Dec; 171(11):785-795. PubMed ID: 31658472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness and cost-utility of an Acceptance and Commitment Therapy intervention vs. a Cognitive Behavioral Therapy intervention for older adults with anxiety symptoms: A randomized controlled trial.
    Witlox M; Kraaij V; Garnefski N; Bohlmeijer E; Smit F; Spinhoven P
    PLoS One; 2022; 17(1):e0262220. PubMed ID: 35081130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.